Tumor-infiltrating lymphocytes (TILs) have been investigated as prognostic factors in melanoma. Recent advancements in assessing the tumor microenvironment in the setting of more widespread use of immune checkpoint blockade have reignited interest in identifying predictive biomarkers. This review examines the function and significance of TILs in cutaneous melanoma, evaluating their potential as prognostic and predictive markers. A literature search was conducted on papers covering tumor infiltrating lymphocytes in cutaneous melanoma available online in PubMed and Web of Science from inception to 1 December 2023, supplemented by citation searching. This article encompasses the assessment of TILs, the role of TILs in the immune microenvironment, TILs as a prognostic factor, TILs as a predictive factor for immunotherapy response, and clinical applications of TILs in the treatment of cutaneous melanoma. Tumor-infiltrating lymphocytes play a heterogeneous role in cutaneous melanoma. While they have historically been associated with improved survival, their status as independent prognostic or predictive factors remains uncertain. Novel methods of TIL assessment, such as determination of TIL subtypes and molecular signaling, demonstrate potential for predicting therapeutic response. Further, while their clinical utility in risk-stratification in melanoma treatment shows promise, a lack of consensus data hinders standardized application.
Melanoma is the fifth most common cancer in the United States and accounts for the majority of all skin cancer-related deaths, making it the most lethal cutaneous malignancy. Systemic adjuvant therapy for stage IIB-IV melanoma is now approved for patients who have undergone surgical resection, given the appreciable risk of recurrence and mortality in this patient population. Despite the lower stage, high-risk stage II melanoma (stage IIB/IIC) can often exhibit an even more aggressive course when compared to stage IIIA/IIIB disease, thus justifying consideration of adjuvant therapy in these patients. In this review, we highlight the current standard of practice for the treatment of stage IIB/C melanoma, with a focus on adjuvant therapies supported by published landmark clinical trials, including anti-PD-1 therapy. Notably, adjuvant therapies approved thus far in this patient population have demonstrated an improvement in recurrence-free survival, while their impact on overall survival is pending. Finally, this review highlights currently ongoing trials and future directions for research and treatment possibilities for high-risk clinical stage II melanoma.
Background: Malnutrition significantly impacts surgical outcomes yet is difficult to identify preoperatively. Few studies have investigated the association between comprehensive body composition assessment and malnutrition in males and females separately. This study evaluates sex-specific associations between preoperative imaging-derived body composition features and malnutrition in abdominal surgery patients. Methods: This cross-sectional study included patients who underwent a preoperative abdominal computed tomography scan and elective abdominal surgery at a single institution (2018–2021). A deep learning algorithm quantified five muscle groups and two fat depots from CT scans. Clinical malnutrition was diagnosed by registered dietitians using standardized criteria. Sex-specific associations between imaging features and malnutrition were evaluated using logistic regression. Results: Among 1143 patients, 20.2% had clinical malnutrition, with prevalence varying by procedure type (3.5–38.2%). Malnutrition was associated with reduced muscle volume for both sexes; however, myosteatosis was only associated with malnutrition in females. In males, malnutrition was associated with decreased psoas volume (OR: 0.58, 95% CI [0.41–0.82]), decreased quadratus lumborum volume (OR: 0.52, 95% CI [0.35–0.77]), and reduced erector spinae attenuation (OR 0.58, 95% CI [0.41–0.82]). In females, decreased psoas volume (OR 0.56, 95% CI [0.41–0.77]) and attenuation (OR 0.59, 95% CI [0.44–0.79]) were associated with malnutrition. Both sexes showed increased subcutaneous fat attenuation (males: OR 1.58, 95% CI [1.22–2.04]; females: OR 1.96, 95% CI [1.54–2.50]) and visceral fat attenuation (males: OR 1.43 95% CI [1.07–1.90]; females: OR 1.68 95% CI [1.29–2.20]) associated with malnutrition. Conclusions: Males and females exhibit distinct body composition features associated with clinical malnutrition. Comprehensive analysis of muscle and fat characteristics reveals these sex-specific relationships, providing foundational knowledge for future development of predictive tools to enable earlier identification of patients at higher nutrition-related surgical risk.
14 May 2025 in Journal of Gastrointestinal Surgery